NCT05408585

Brief Summary

In this study, the minimum effective concentration required for supra-inguinal fascia iliaca block applied in patients undergoing arthroscopic knee surgery is aimed. The same volume will be used in all of the block applications in the study, and the local anesthetic concentration used will be determined by increasing or decreasing according to the success of the previous block. The primary goal of the study is block success.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
65

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Jun 2022

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

May 30, 2022

Completed
8 days until next milestone

First Posted

Study publicly available on registry

June 7, 2022

Completed
Same day until next milestone

Study Start

First participant enrolled

June 7, 2022

Completed
9 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

February 27, 2023

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

February 27, 2023

Completed
Last Updated

February 28, 2023

Status Verified

February 1, 2023

Enrollment Period

9 months

First QC Date

May 30, 2022

Last Update Submit

February 27, 2023

Conditions

Outcome Measures

Primary Outcomes (1)

  • Block Success

    Block success will be evaluated on the post-operative period in the antrior and lateral of thigh using pinprick test.

    at 6, 12, 24 hours

Secondary Outcomes (1)

  • Tramadol Consumption

    24 hours

Study Arms (2)

SIFIB with concentration "A"

ACTIVE COMPARATOR

The patients were placed in a supine position, and their skin was disinfected and draped. A linear ultrasonography probe was positioned parasagittally and slightly medially on the anterior superior iliac spine. The sartorius, iliacus, internal oblique muscles and deep circumflex iliac artery were visualized. A 80-mm peripheral nerve block needle was advanced, using the in-plane technique, from cranial to caudal until the tip was positioned between the internal oblique and iliacus muscles. Suprainguinal fascia iliaca block will be performed with concentration "A".

Other: Regional Anesthesia Techniques

SIFIB with concentration "B"

ACTIVE COMPARATOR

The patients were placed in a supine position, and their skin was disinfected and draped. A linear ultrasonography probe was positioned parasagittally and slightly medially on the anterior superior iliac spine. The sartorius, iliacus, internal oblique muscles and deep circumflex iliac artery were visualized. A 80-mm peripheral nerve block needle was advanced, using the in-plane technique, from cranial to caudal until the tip was positioned between the internal oblique and iliacus muscles.Suprainguinal fascia iliaca block performed with concentration "B"

Other: Regional Anesthesia Techniques

Interventions

Fascial Plane Blocks

SIFIB with concentration "A"SIFIB with concentration "B"

Eligibility Criteria

Age18 Years - 65 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Patients undergoing arthroscopic knee surgery under spinal anesthesia will be included in the study.

You may not qualify if:

  • Conditions where regional anesthesia is contraindicated (coagulopathy, infection..)
  • Patients who underwent general anesthesia for the surgical procedure
  • Patients who do not want to be included in the study by not signing the voluntary consent form.
  • Patients with advanced dementia, orientation-cooperation problems
  • History of allergy to local anesthetic drugs
  • Infection status at the injection site

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Samsun University

Samsun, Turkey (Türkiye)

Location

Related Publications (2)

  • Dixon WJ. Staircase bioassay: the up-and-down method. Neurosci Biobehav Rev. 1991 Spring;15(1):47-50. doi: 10.1016/s0149-7634(05)80090-9.

    PMID: 2052197BACKGROUND
  • Durham SD, Flournoy N, Rosenberger WF. A random walk rule for phase I clinical trials. Biometrics. 1997 Jun;53(2):745-60.

MeSH Terms

Conditions

Agnosia

Condition Hierarchy (Ancestors)

Perceptual DisordersNeurobehavioral ManifestationsNeurologic ManifestationsNervous System DiseasesSigns and SymptomsPathological Conditions, Signs and Symptoms

Study Officials

  • SERKAN TULGAR, M.D.

    CLINICAL CHIEF

    STUDY DIRECTOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
CARE PROVIDER, OUTCOMES ASSESSOR
Masking Details
All blocks will be performed by the same experienced anesthetist to ensure block quality and homogeneity. The anesthetist applying the block will not take part in the patient follow-up, the independent assistant following the patient will be blinded to the study.
Purpose
SUPPORTIVE CARE
Intervention Model
PARALLEL
Model Details: As suggested by Durham et al and described by Dixon, study randomization will be performed using the biased-coin design up-down sequential method.
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

May 30, 2022

First Posted

June 7, 2022

Study Start

June 7, 2022

Primary Completion

February 27, 2023

Study Completion

February 27, 2023

Last Updated

February 28, 2023

Record last verified: 2023-02

Data Sharing

IPD Sharing
Will not share

Locations